ProGen Life Sciences Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

ProGen Life Sciences General Information

Description

Developer of diagnostic biomarkers designed to guide physicians in choosing the most effective therapeutic approach. The company's diagnostic biomarkers includes treatment regimens for various cancer based on the expression of molecular biomarkers, enabling oncologists to guide using proprietary tests and optimizing the therapeutic regimens available for cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 25 Health Science Drive
  • NY 11790
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProGen Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view ProGen Life Sciences’s complete valuation and funding history, request access »

ProGen Life Sciences Executive Team (1)

Name Title Board Seat Contact Info
Mohan Chellani Ph.D Founder & President
To view ProGen Life Sciences’s complete executive team members history, request access »

ProGen Life Sciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Long Island High Technology Incubator Accelerator/Incubator 000 0000 000000 0
To view ProGen Life Sciences’s complete investors history, request access »